The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients
Open accessAbstract
Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This allows for early discrimination between diabetic and healthy individuals [178].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [178]
Citations
Cites
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Self-citationFoulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., & Weir, R. S. (1986) · Diabetologia · doi:10.1007/bf00452061 · Cited by 469
Itoh, N., Hanafusa, T., Miyazaki, A., Miyagawa, J.-I., Yamagata, K., Yamamoto, K., Waguri, M., Imagawa, A., Tamura, S., & Inada, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116835 · Cited by 347
Hänninen, A. L. M., Jalkanen, S., Salmi, M., Toikkanen, S., Nikolakaros, G., & Simell, O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116067 · Cited by 242
Müller, K. H., Skepper, J. N., Pósfai, M., Trivedi, R. A., Howarth, S. P. S., Corot, C., Lancelot, E., Thompson, P. W., Brown, A. P., & Gillard, J. H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.003 · Cited by 237
Foulis, A. K., & Stewart, J. A. (1984) · Diabetologia · doi:10.1007/bf00262221 · Cited by 233
Imaging inflammation of the pancreatic islets in type 1 diabetes
Denis, M. C., Mahmood, U., Benoist, C. O., Mathis, D. J., & Weissleder, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404307101 · Cited by 176
Self-citationL�hr, M., & Kl�ppel, G. (1987) · Diabetologia · doi:10.1007/bf00275740 · Cited by 171
A comprehensive guide to antibody and T‐cell responses in type 1 diabetes
Lieberman, S. M., & DiLorenzo, T. P. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00152.x · Cited by 170
The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland.
Henderson, J. R., Daniel, P. M., & Fraser, P. A. (1981) · Gut · doi:10.1136/gut.22.2.158 · Cited by 169
Research works printed but not linked: 2
- Papaccio, 1993, Histol Histopathol., 8, 751
- Signore, 1996, Clin Exp Rheumatol., 14 suppl 15, S41
Cited by
Sorted by citations
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,925
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W. C., Farokhzad, O. C., Barry, S. T., Gabizón, A., Grodzinski, P. A., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,493
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809
Self-citation
Metadata
- Authors
- Gaglia, J. L., Guimaraes, A. R., Harisinghani, M., Turvey, S. E., Jackson, R., Benoist, C., Mathis, D., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-01-04
- Volume
- 121
- Issue
- 1
- Pages
- 442-445
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3007157
- OpenAlex
- W2067753785
- Cited by
- 209
- References
- 21
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 11 · 2022: 5 · 2021: 16 · 2020: 9 · 2019: 13 · 2018: 14 · 2017: 15 · 2016: 19 · 2015: 26 · 2014: 17 · 2013: 20 · 2012: 22
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Cancer Research Institute
- Pfizer
- RSNA Research and Education Foundation
- Radiological Society of North America
- Harvard University
- Harvard Catalyst (UL1-RR025758, RR025758)
- Covis Pharma
- National Institutes of Health (5u54ca119349-05, P50-CA86355, U54-CA119349, CA119349, CA86355)
- U.S. Public Health Service (P01-A1-054904)
- National Heart, Lung, and Blood Institute (U01HL080731)
- National Cancer Institute (P50-CA-86355, U24CA092782, P50CA086355, U54 CA-119349)
- National Center for Research Resources (UL1RR025758)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Keywords
- type 1A diabetes, insulitis, pancreatic islet inflammation, non-invasive imaging, magnetic nanoparticles, ferumoxtran-10, magnetic resonance imaging, monocyte/macrophage recruitment, microvascular changes, autoimmune disease
- MeSH terms
- Adolescent, Adult, Dextrans, Diabetes Mellitus, Type 1, Female, Humans, Inflammation, Islets of Langerhans, Macrophages, Magnetic Resonance Imaging, Male, Microcirculation, Monocytes, Case-Control Studies, Young Adult, Magnetite Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
